Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04148989 · ClinicalTrials.gov registry record · NA
Effects of Code Sepsis Implementation on Emergency Department (ED) Sepsis Care
A NA study, sponsored by Intermountain Health Care.
- Completed
- Registry status
- NA
- Development phase
- 180,402
- Enrollment target
NCT04148989: Completed NA study, sponsored by Intermountain Health Care.
NCT04148989 is a NA study that has completed, run by Intermountain Health Care. The registered enrollment target is 180,402 participants, above the 1,401-participant average among 58,714 other NA trials with a reported enrollment target (12777% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04148989, a NA study, has completed, sponsored by Intermountain Health Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 180,402 participants
- Enrollment target
Study Summary
Sepsis is a life-threatening complication of infection that can be difficult to recognize and treat promptly. Timely administration of antibiotics for emergency department (ED) patients with sepsis is challenging. The goal of this study is to determine the potential effectiveness and unintended consequences of reorganizing ED care for patients with suspected sepsis.
Primary Outcome
Time from sepsis patients' emergency department arrival to intravenous (or equivalent) antibiotic initiation
Interventions
- OTHER Code Sepsis protocol (full implementation)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180,402 participants |
| Start Date | 2018-11-13 |
| Est. Completion | 2023-12-28 |
| Phase | NA |
What the finished NCT04148989 record still lists
NCT04148989 is an interventional study that assigns participants to a tested intervention. Its 180,402 participants enrollment target places it among the larger protocols in the corpus, above the 1,401-participant average among 58,714 other NA trials with a reported enrollment target (12777% higher).
The record links to 0 conditions, and to 1 intervention - of which Code Sepsis protocol (full implementation) is the first listed.
NCT04148989 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04148989 about?
NCT04148989 is a clinical study titled "Effects of Code Sepsis Implementation on Emergency Department (ED) Sepsis Care". Sepsis is a life-threatening complication of infection that can be difficult to recognize and treat promptly. Timely administration of antibiotics for emergency department (ED) patients with sepsis is challenging. The goal of this study is to determine the potential effectiveness and unintended cons...
What is the current status of trial NCT04148989?
This trial is currently completed. It is a NA study. The enrollment target is 180,402 participants. The study started on 2018-11-13. Estimated completion is 2023-12-28.
What interventions are being tested in trial NCT04148989?
The interventions under investigation include: Code Sepsis protocol (full implementation) (OTHER).
Who is sponsoring clinical trial NCT04148989?
This trial is sponsored by Intermountain Health Care, which has 85 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04148989's enrollment target sits among peer trials
180,402 1st of 2000 higher than 2,000 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06090578 · 180,000 participants · NA
TabCAT Brain Health Assessment in Primary Care
- NCT06917339 · 156,000 participants
Retrospective Analyses of TrakStar Database
- NCT06232551 · 152,000 participants · NA
Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism
- NCT05994482 · 130,000 participants
Surveillance Colonoscopy in Older Adults: The SurvOlderAdults Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI